Cargando…

Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma

IMPORTANCE: Outcomes of localized malignant pleural mesothelioma (MPM) remain poor despite multimodality therapy. It is unclear what role disparities have in the overall survival (OS) of patients with operable MPM. OBJECTIVE: To examine survival disparities associated with social determinants of hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alnajar, Ahmed, Kareff, Samuel A., Razi, Syed S., Rao, J. Sunil, De Lima Lopes, Gilberto, Nguyen, Dao M., Villamizar, Nestor, Rodriguez, Estelamari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037156/ https://www.ncbi.nlm.nih.gov/pubmed/36951862 http://dx.doi.org/10.1001/jamanetworkopen.2023.4261

Ejemplares similares

Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis
por: Kareff, Samuel A., et al.
Publicado: (2023)

Disparities in Spatial Access to Emergency Surgical Services in the US
por: McCrum, Marta L., et al.
Publicado: (2022)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Racial and Ethnic Disparities in Geographic Access to Autism Resources Across the US
por: Liu, Bennett M., et al.
Publicado: (2023)

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
por: Meirson, Tomer, et al.
Publicado: (2022)

Association Between the COVID-19 Pandemic and Disparities in Access to Major Surgery in the US
por: Glance, Laurent G., et al.
Publicado: (2022)

A narrative review of the health disparities associated with malignant pleural mesothelioma
por: Freudenberger, Devon C., et al.
Publicado: (2021)

Achieving opioid-free discharge following robotic thoracic surgery: A single-institution experience
por: Gross, Daniel J., et al.
Publicado: (2023)

Evaluation of Between-County Disparities in Premature Mortality Due to Stroke in the US
por: Song, Suhang, et al.
Publicado: (2021)

The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections
por: Gross, Daniel J., et al.
Publicado: (2023)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Pleural Mesothelioma in the Era of Immunotherapy
por: Chevallier, Mathieu, et al.
Publicado: (2023)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

Implementation of an enhanced recovery after thoracic surgery care pathway for thoracotomy patients—achieving better pain control with less (schedule II) opioid utilization
por: Kodia, Karishma, et al.
Publicado: (2021)

Optimization of an Enhanced Recovery After Surgery protocol for opioid-free pain management following robotic thoracic surgery
por: Kodia, Karishma, et al.
Publicado: (2022)

Recurrent Pericardial and Pleural Effusion due to Pericardial Pleomorphic Mesothelioma
por: Segura-Méndez, Bárbara, et al.
Publicado: (2022)

COVID-19–Related Insurance Coverage Changes and Disparities in Access to Care Among Low-Income US Adults in 4 Southern States
por: Figueroa, Jose F., et al.
Publicado: (2021)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

Pleural mesothelioma in a couple of brothers
por: Bianchi, Claudio, et al.
Publicado: (2013)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Life Expectancy in Pleural and Peritoneal Mesothelioma
por: Shavelle, Robert, et al.
Publicado: (2017)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016)

Pleural tuberculosis mimicking malignant mesothelioma
por: Dawood, Wajahat, et al.
Publicado: (2019)

Cytomegalovirus infection in malignant pleural mesothelioma
por: Hunter-Schlichting, DeVon, et al.
Publicado: (2021)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

Pleural mesothelioma in a circus worker
por: Mensi, Carolina, et al.
Publicado: (2021)

KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8iusnh0lqgg3ep0o6ghg6qnv22